ExodusPoint Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12K | Buy |
+12,241
| New | +$12K | ﹤0.01% | 1320 |
|
|
2024
Q2 | – | Sell |
-319,058
| Closed | -$766K | – | 1644 |
|
|
2024
Q1 | $766K | Buy |
+319,058
| New | +$766K | 0.01% | 918 |
|
|
2023
Q2 | – | Sell |
-15,536
| Closed | -$38K | – | 1984 |
|
|
2023
Q1 | $38K | Buy |
+15,536
| New | +$38K | ﹤0.01% | 1577 |
|
|
2022
Q2 | – | Sell |
-16,301
| Closed | -$34K | – | 2163 |
|
|
2022
Q1 | $34K | Sell |
16,301
-17,600
| -52% | -$36.7K | ﹤0.01% | 2026 |
|
|
2021
Q4 | $134K | Buy |
33,901
+9,700
| +40% | +$38.3K | ﹤0.01% | 1861 |
|
|
2021
Q3 | $116K | Sell |
24,201
-7,637
| -24% | -$36.6K | ﹤0.01% | 1830 |
|
|
2021
Q2 | $146K | Sell |
31,838
-53,777
| -63% | -$247K | ﹤0.01% | 1989 |
|
|
2021
Q1 | $503K | Buy |
+85,615
| New | +$503K | 0.01% | 1297 |
|
|
2020
Q3 | – | Sell |
-25,622
| Closed | -$51K | – | 1961 |
|
|
2020
Q2 | $51K | Buy |
+25,622
| New | +$51K | ﹤0.01% | 1656 |
|
|
2019
Q4 | – | Sell |
-136,840
| Closed | -$412K | – | 1673 |
|
|
2019
Q3 | $412K | Buy |
+136,840
| New | +$412K | 0.01% | 713 |
|